Videos / Fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy
In this Product Explainer, Respiratory Physician Dr Adrian Barnett explains the role of fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (5 mins).
This educational activity was developed by Healthed at the request of and with funding from GSK.
PM-AU-FVU-PPTX-230007 Approved July 2023.
Heart Failure – Assessment and Monitoring in Primary Care
Heart Failure – Demystifying Pharmacological Management for GPs
COPD Update
Iron Deficiency in Children & Young People
expert
Respiratory Physician, Gold Coast University Hospital